Cite
Topical ruxolitinib in the management of frontal fibrosing alopecia and/or lichen planopilaris: A single-center retrospective cohort study.
MLA
Williams, Kimberly N., et al. “Topical Ruxolitinib in the Management of Frontal Fibrosing Alopecia and/or Lichen Planopilaris: A Single-Center Retrospective Cohort Study.” Journal of the American Academy of Dermatology, vol. 92, no. 1, Jan. 2025, pp. 170–72. EBSCOhost, https://doi.org/10.1016/j.jaad.2024.09.032.
APA
Williams, K. N., Perez, S. M., Burroway, B., & Tosti, A. (2025). Topical ruxolitinib in the management of frontal fibrosing alopecia and/or lichen planopilaris: A single-center retrospective cohort study. Journal of the American Academy of Dermatology, 92(1), 170–172. https://doi.org/10.1016/j.jaad.2024.09.032
Chicago
Williams, Kimberly N., Sofia M. Perez, Brandon Burroway, and Antonella Tosti. 2025. “Topical Ruxolitinib in the Management of Frontal Fibrosing Alopecia and/or Lichen Planopilaris: A Single-Center Retrospective Cohort Study.” Journal of the American Academy of Dermatology 92 (1): 170–72. doi:10.1016/j.jaad.2024.09.032.